Suchergebnisse - "Benzhydryl Compounds therapeutic use"
-
1
Autoren: et al.
Quelle: Croat Med J
Schlagwörter: Heart Failure, Male, heart failure, Dapagliflozin, Middle Aged, Sodium-Glucose Transporter 2 Inhibitors / therapeutic use, Glucosides / therapeutic use, Treatment Outcome, Glucosides, Benzhydryl Compounds / therapeutic use, Chronic Disease, Humans, Female, Registries, Benzhydryl Compounds, Sodium-Glucose Transporter 2 Inhibitors, Heart Failure / drug therapy, Research Article, Aged
Dateibeschreibung: application/pdf
-
2
Autoren: et al.
Quelle: Emanuelsson, F, Jensen, J, Omar, M, Jürgens, M, Kistorp, C, Brandt-Jacobsen, N H, Møller, J E, Schou, M, Bechmann, L E, Larsen, E L, Nordestgaard, B G & Benn, M 2025, ' Effect of empagliflozin on plasma lipids and lipoproteins in type 2 diabetes and heart failure – Empire HF and SIMPLE ', Journal of Clinical Lipidology, vol. 19, no. 2, pp. 276-285 . https://doi.org/10.1016/j.jacl.2024.12.015
Schlagwörter: Male, Lipoproteins, Heart failure, Glycated Hemoglobin/metabolism, Double-Blind Method, Glucosides, Benzhydryl Compounds/therapeutic use, Lipoproteins/blood, Diabetes Mellitus, Heart Failure/blood, Humans, Benzhydryl Compounds, Sodium-Glucose Transporter 2 Inhibitors, Aged, Glycated Hemoglobin, Heart Failure, Lipids/blood, Type 2 diabetes, Middle Aged, Sodium-glucose cotransporter-2 inhibition, Lipids, Glucosides/therapeutic use, Cholesterol, Type 2/drug therapy, Diabetes Mellitus, Type 2, Female, Lipoprotein(a)
Dateibeschreibung: application/pdf
-
3
Autoren: et al.
Quelle: JACC. Heart failure. 10(2):104-118
Schlagwörter: *Benzhydryl Compounds/therapeutic use, *Glucosides/therapeutic use, *Heart Failure/drug therapy, Clinical Trials as Topic, heart failure, Humans, MAGGIC, PREDICT-HF, prognostic model, Prospective Studies, Risk Assessment, risk score, sodium-glucose cotransporter 2 inhibitor, survival
Dateibeschreibung: print
-
4
Autoren: et al.
Weitere Verfasser: et al.
Quelle: Clin Drug Investig
Schlagwörter: Benzhydryl Compounds/therapeutic use [MeSH], Female [MeSH], Sodium-Glucose Transporter 2 Inhibitors/therapeutic use [MeSH], Cost-Benefit Analysis [MeSH], Aged [MeSH], Humans [MeSH], Middle Aged [MeSH], France [MeSH], Benzhydryl Compounds/economics [MeSH], Renal Insufficiency, Chronic/economics [MeSH], Glucosides/therapeutic use [MeSH], Male [MeSH], Markov Chains [MeSH], Sodium-Glucose Transporter 2 Inhibitors/economics [MeSH], Glucosides/economics [MeSH], Original Research Article, Renal Insufficiency, Chronic/drug therapy [MeSH], Male, [SDV]Life Sciences [q-bio], Cost-Benefit Analysis, Economie sociale, I.I1.I12, treatment of chronic kidney disease (CKD), Trial, I.I1.I11, Education, Glucosides, Humans, and Welfare::I1 - Health::I12 - Health Behavior, Benzhydryl Compounds, Renal Insufficiency, Chronic, Sodium-Glucose Transporter 2 Inhibitors, Aged, and Welfare::I1 - Health::I11 - Analysis of Health Care Markets, Middle Aged, healthcare system, Markov Chains, [SDV] Life Sciences [q-bio], economic outcomes, Female, France, I - Health
Dateibeschreibung: application/pdf
-
5
Autoren: et al.
Quelle: Cardiovasc Diabetol
Cardiovascular Diabetology, Vol 24, Iss 1, Pp 1-15 (2025)Schlagwörter: Nitroprusside, Male, Microvessels/drug effects physiopathology, Time Factors, Benzhydryl Compounds/therapeutic use adverse effects, Vasodilator Agents, Heart failure, Laser speckle contrast analysis, Left/drug effects, Ventricular Function, Left, Heart Failure/physiopathology drug therapy diagnosis, Glucosides, 80 and over, Ventricular Function, Insulin, Diseases of the circulatory (Cardiovascular) system, Humans, Benzhydryl Compounds, Forearm/blood supply, Sodium-Glucose Transporter 2 Inhibitors, Aged, Heart Failure, Aged, 80 and over, Research, Microcirculation, Endothelial function, Stroke Volume, Recovery of Function, Middle Aged, Acetylcholine, Microcirculation/drug effects, Forearm, Glucosides/therapeutic use adverse effects, Treatment Outcome, Vasodilator Agents/administration & dosage, RC666-701, SGLT-2 inhibitor, Microvessels, Quality of Life, Stroke Volume/drug effects, Female, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use adverse effects
-
6
Autoren: et al.
Weitere Verfasser: et al.
Quelle: Journal Of The American College Of Cardiology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Institut de Recerca Germans Trias i Pujol (IGTP)
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Docusalut
Conselleria de Salut i Consum del Govern de les Illes BalearsSchlagwörter: Male, Anciano, Empagliflozin, empagliflozin, Myocardial Infarction, Heart Failure* / drug therapy, acute myocardial infarction, heart failure, Heart failure, Ventricular Function, Left* / drug effects, Acute myocardial infarction, Ventricular Function, Left, 03 medical and health sciences, 0302 clinical medicine, Glucosides, Double-Blind Method, Hospitalization / statistics & numerical data, Método Doble Ciego, Glucosides* / therapeutic use, Humans, Heart Failure* / mortality, Benzhydryl Compounds, Masculino, Sodium-Glucose Transporter 2 Inhibitors, Aged, left ventricular dysfunction, Heart Failure, Persona de Mediana Edad, congestion, Left ventricular dysfunction, Femenino, Stroke Volume, Middle Aged, Myocardial Infarction* / epidemiology, Sodium-Glucose Transporter 2 Inhibitors* / therapeutic use, Humanos, 3. Good health, Hospitalization, Myocardial Infarction* / drug therapy, Estudios de Seguimiento, Congestion, Benzhydryl Compounds* / therapeutic use, Female, Stroke Volume / drug effects, Follow-Up Studies
Dateibeschreibung: application/pdf
Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/38588929
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=15123
https://hdl.handle.net/20.500.13003/20330
https://hdl.handle.net/11370/83ecf242-c651-40ca-85d3-f277c94c2da6
https://research.rug.nl/en/publications/83ecf242-c651-40ca-85d3-f277c94c2da6
https://doi.org/10.1016/j.jacc.2024.03.405 -
7
Autoren: et al.
Quelle: Adv Ther
Schlagwörter: Male, Heart Failure, ddc:610, Middle Aged, Benzhydryl Compounds/therapeutic use [MeSH], Sodium-Glucose Transporter 2 Inhibitors/therapeutic use [MeSH], Aged [MeSH], Diabetes Mellitus, Type 2/drug therapy [MeSH], Randomized Controlled Trials as Topic [MeSH], Hypoglycemic Agents/adverse effects [MeSH], Male [MeSH], Adverse drug event, Hypoglycemic Agents/therapeutic use [MeSH], Glucosides/adverse effects [MeSH], Original Research, SGLT2 inhibitors, Sodium-Glucose Transporter 2 Inhibitors/adverse effects [MeSH], Adverse drug reaction, Female [MeSH], Benzhydryl Compounds/adverse effects [MeSH], Diabetes Mellitus, Type 2/complications [MeSH], Humans [MeSH], Drug safety, Cardiovascular Diseases [MeSH], Heart Failure [MeSH], Middle Aged [MeSH], Renal Insufficiency, Chronic [MeSH], Glucosides/therapeutic use [MeSH], Empagliflozin, Glucosides, Diabetes Mellitus, Type 2, Cardiovascular Diseases, Humans, Hypoglycemic Agents, Female, Benzhydryl Compounds, Renal Insufficiency, Chronic, Sodium-Glucose Transporter 2 Inhibitors, Aged, Randomized Controlled Trials as Topic
Dateibeschreibung: application/pdf
Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/38771475
https://repository.publisso.de/resource/frl:6508947
https://nbn-resolving.org/urn:nbn:de:bvb:20-opus-398088
https://opus.bibliothek.uni-wuerzburg.de/frontdoor/index/index/docId/39808
https://doi.org/10.1007/s12325-024-02879-w
https://opus.bibliothek.uni-wuerzburg.de/files/39808/12325_2024_Article_2879.pdf -
8
Autoren: et al.
Quelle: Clin Exp Nephrol
Schlagwörter: Male, Kidney, 01 natural sciences, 03 medical and health sciences, 0302 clinical medicine, Glucosides, Japan, Double-Blind Method, Humans, Albuminuria, Renal Insufficiency, Chronic, Benzhydryl Compounds, 0101 mathematics, Sodium-Glucose Transporter 2 Inhibitors, Aged, Middle Aged, 16. Peace & justice, 3. Good health, Treatment Outcome, Cardiovascular Diseases, Disease Progression, Benzhydryl Compounds/therapeutic use [MeSH], Double-Blind Method [MeSH], Kidney/drug effects [MeSH], Sodium-Glucose Transporter 2 Inhibitors/therapeutic use [MeSH], Renal Insufficiency, Chronic/physiopathology [MeSH], Disease Progression [MeSH], Renal Insufficiency, Chronic/diagnosis [MeSH], Aged [MeSH], Cardiovascular disease, Kidney/physiopathology [MeSH], Male [MeSH], Glucosides/adverse effects [MeSH], Glomerular Filtration Rate/drug effects [MeSH], Kidney Failure, Chronic/drug therapy [MeSH], Sodium-Glucose Transporter 2 Inhibitors/adverse effects [MeSH], Female [MeSH], Benzhydryl Compounds/adverse effects [MeSH], Humans [MeSH], Albuminuria/drug therapy [MeSH], Treatment Outcome [MeSH], Cardiovascular Diseases [MeSH], Middle Aged [MeSH], Japan/epidemiology [MeSH], Glucosides/therapeutic use [MeSH], Kidney function, Rapid Communication, Randomised trial, Sodium–glucose co-transporter-2 inhibitor, Renal Insufficiency, Chronic/drug therapy [MeSH], Kidney Failure, Chronic, Female, Glomerular Filtration Rate
-
9
Autoren: et al.
Quelle: Anaesthesiologie
Schlagwörter: Kasuistiken, Benzhydryl Compounds/therapeutic use [MeSH], Sodium-Glucose Transporter 2 Inhibitors/therapeutic use [MeSH], Cardiac Surgical Procedures/adverse effects [MeSH], Benzhydryl Compounds/adverse effects [MeSH], Ketosis/chemically induced [MeSH], Postoperative Complications/drug therapy [MeSH], Aged [MeSH], Humans [MeSH], Glucosides/therapeutic use [MeSH], Male [MeSH], Glucosides/adverse effects [MeSH], Sodium-Glucose Transporter 2 Inhibitors/adverse effects [MeSH]
Zugangs-URL: https://repository.publisso.de/resource/frl:6522254
-
10
Autoren:
Quelle: Basic Res Cardiol
Schlagwörter: Glucosides, Atrial Fibrillation, Humans, Animals, Atrial Fibrillation/physiopathology [MeSH], Benzhydryl Compounds/therapeutic use [MeSH], Sodium-Glucose Transporter 2 Inhibitors/therapeutic use [MeSH], Anti-Arrhythmia Agents/therapeutic use [MeSH], Glucosides/therapeutic use [MeSH], Anti-Arrhythmia Agents/administration, Humans [MeSH], Glucosides/administration, Atrial Fibrillation/drug therapy [MeSH], Letter to the Editor, Animals [MeSH], Benzhydryl Compounds, Sodium-Glucose Transporter 2 Inhibitors, Anti-Arrhythmia Agents
-
11
Autoren: et al.
Quelle: Cardiovasc Diabetol
Cardiovascular Diabetology, Vol 23, Iss 1, Pp 1-7 (2024)Schlagwörter: Male, Time Factors, Myocardial Infarction, Risk Assessment, 03 medical and health sciences, Diabetes mellitus, 0302 clinical medicine, Glucosides, Risk Factors, Recurrence, Sodium-glucose transporter 2 inhibitors, Diseases of the circulatory (Cardiovascular) system, Humans, Myocardial infarction, Type 2, Benzhydryl Compounds, Sodium-Glucose Transporter 2 Inhibitors, Aged, Research, Middle Aged, 3. Good health, Benzhydryl Compounds/therapeutic use [MeSH], Sodium-Glucose Transporter 2 Inhibitors/therapeutic use [MeSH], Aged [MeSH], Risk Assessment [MeSH], Diabetes Mellitus, Type 2/drug therapy [MeSH], Risk Factors [MeSH], Diabetes Mellitus, Type 2/mortality [MeSH], Male [MeSH], Myocardial Infarction/diagnosis [MeSH], Glucosides/adverse effects [MeSH], Sodium-Glucose Transporter 2 Inhibitors/adverse effects [MeSH], Diabetes Mellitus, Type 2/diagnosis [MeSH], Female [MeSH], Myocardial Infarction/mortality [MeSH], Benzhydryl Compounds/adverse effects [MeSH], Diabetes Mellitus, Type 2/complications [MeSH], Myocardial Infarction/prevention, Humans [MeSH], Treatment Outcome [MeSH], Middle Aged [MeSH], Time Factors [MeSH], Recurrence [MeSH], Myocardial Infarction/epidemiology [MeSH], Glucosides/therapeutic use [MeSH], Treatment Outcome, Diabetes Mellitus, Type 2, RC666-701, Female
-
12
Autoren: et al.
Quelle: Cardiovasc Diabetol
Cardiovascular Diabetology, Vol 23, Iss 1, Pp 1-12 (2024)Schlagwörter: Male, Time Factors, Linagliptin, Pulse Wave Analysis, Kidney, 03 medical and health sciences, Vascular Stiffness, 0302 clinical medicine, Glucosides, Diseases of the circulatory (Cardiovascular) system, Humans, Insulin, Diabetic Nephropathies, Benzhydryl Compounds, Sodium-Glucose Transporter 2 Inhibitors, Aged, PWV, Research, Middle Aged, Metformin, 3. Good health, Treatment Outcome, Diabetes Mellitus, Type 2, RC666-701, GFR decline, Female, Drug Therapy, Combination, Benzhydryl Compounds/therapeutic use [MeSH], Kidney/drug effects [MeSH], Sodium-Glucose Transporter 2 Inhibitors/therapeutic use [MeSH], Aged [MeSH], Diabetic Nephropathies/diagnosis [MeSH], Diabetes Mellitus, Type 2/physiopathology [MeSH], Sodium-Glucose Transporter 2 [MeSH], Diabetes Mellitus, Type 2/drug therapy [MeSH], Metformin/therapeutic use [MeSH], Kidney/physiopathology [MeSH], Hypoglycemic Agents/adverse effects [MeSH], Male [MeSH], Hypoglycemic Agents/therapeutic use [MeSH], Glucosides/adverse effects [MeSH], Clinical Relevance [MeSH], Drug Therapy, Combination [MeSH], SGLT2 inhibitors, Glomerular Filtration Rate/drug effects [MeSH], Sodium-Glucose Transporter 2 Inhibitors/adverse effects [MeSH], Diabetes Mellitus, Type 2/diagnosis [MeSH], Female [MeSH], Linagliptin/therapeutic use [MeSH], Benzhydryl Compounds/adverse effects [MeSH], Biomarkers/blood [MeSH], Humans [MeSH], Insulin [MeSH], Linagliptin/adverse effects [MeSH], Treatment Outcome [MeSH], Middle Aged [MeSH], Time Factors [MeSH], Diabetic Nephropathies/physiopathology [MeSH], Glucosides/therapeutic use [MeSH], Diabetic Nephropathies/drug therapy [MeSH], Pulse Wave Analysis [MeSH], Vascular Stiffness/drug effects [MeSH], Glomerular Filtration Rate
-
13
Autoren: et al.
Quelle: Nature medicine. 28(12):2504-2511
Schlagwörter: *Heart Failure/drug therapy, Benzhydryl Compounds/therapeutic use, Glucosides/therapeutic use, Humans, Ventricular Function, Left
Dateibeschreibung: print
-
14
Cost effectiveness of empagliflozin in adult patients with chronic kidney disease in the Netherlands
Autoren: et al.
Quelle: Slob, B, Fens, T, Weersma, M, Postma, M, Boersma, C & de Jong, L 2024, 'Cost effectiveness of empagliflozin in adult patients with chronic kidney disease in the Netherlands', PLoS ONE, vol. 19, no. 12, e0315509. https://doi.org/10.1371/journal.pone.0315509
Schlagwörter: Humans, Glucosides/therapeutic use, Benzhydryl Compounds/therapeutic use, Cost-Benefit Analysis, Renal Insufficiency, Chronic/drug therapy, Netherlands, Male, Female, Middle Aged, Adult, Quality-Adjusted Life Years, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Aged, Markov Chains, Disease Progression, Cost-Effectiveness Analysis
Dateibeschreibung: application/pdf
Relation: info:eu-repo/semantics/altIdentifier/pmid/39656735; info:eu-repo/semantics/altIdentifier/hdl/https://hdl.handle.net/11370/4aac32c1-6b17-4eba-a332-b9ff6d1a1574; info:eu-repo/semantics/altIdentifier/pissn/1932-6203; info:eu-repo/semantics/altIdentifier/eissn/1932-6203
-
15
Autoren: et al.
Quelle: Cardiovasc Diabetol
Cardiovascular Diabetology, Vol 23, Iss 1, Pp 1-17 (2024)Schlagwörter: 0301 basic medicine, 0303 health sciences, Mouse, Research, Diabetes, Empagliflozin, Diabetes Mellitus, Experimental, 3. Good health, Sodium-glucose cotransporter 2 inhibitors, Mice, 03 medical and health sciences, Diabetes Mellitus, Type 2, Glucosides, RC666-701, Diseases of the circulatory (Cardiovascular) system, Humans, Animals, Benzhydryl Compounds/therapeutic use [MeSH], Sodium-Glucose Transporter 2 Inhibitors/therapeutic use [MeSH], Diabetes Mellitus, Type 2/complications [MeSH], Humans [MeSH], Benzhydryl Compounds/pharmacology [MeSH], Diabetes Mellitus, Type 2/drug therapy [MeSH], Stroke recovery, Glucosides/pharmacology [MeSH], Animals [MeSH], Mice [MeSH], Glucosides/therapeutic use [MeSH], Diabetes Mellitus, Experimental/complications [MeSH], Sodium-Glucose Transporter 2 Inhibitors/pharmacology [MeSH], Diabetes Mellitus, Type 2/metabolism [MeSH], Diabetes Mellitus, Experimental/drug therapy [MeSH], Novel Cardioprotective Antidiabetic Medications, Benzhydryl Compounds, Sodium-Glucose Transporter 2 Inhibitors
-
16
Autoren: et al.
Quelle: The Lancet Diabetes & Endocrinology. 9:755-766
Schlagwörter: Male, Glomerular Filtration Rate/drug effects, Chronic/drug therapy, Placebos, 03 medical and health sciences, 0302 clinical medicine, Double-Blind Method, Glucosides, Creatinine/urine, Benzhydryl Compounds/therapeutic use, Diabetes Mellitus, Albuminuria, Humans, Diabetic Nephropathies, Renal Insufficiency/prevention & control, Renal Insufficiency, Benzhydryl Compounds, Renal Insufficiency, Chronic, Sodium-Glucose Transporter 2 Inhibitors, Aged, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Middle Aged, 3. Good health, Glucosides/therapeutic use, Type 2/drug therapy, Diabetes Mellitus, Type 2, Creatinine, Diabetic Nephropathies/drug therapy, Albuminuria/drug therapy, Female, Glomerular Filtration Rate
Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/34619106
https://research.rug.nl/en/publications/c2af467f-022b-4ad1-a4f9-5caab2e93272
https://doi.org/10.1016/S2213-8587(21)00243-6
https://hdl.handle.net/11370/c2af467f-022b-4ad1-a4f9-5caab2e93272
https://pubmed.ncbi.nlm.nih.gov/34619106/
https://www.sciencedirect.com/science/article/pii/S2213858721002436
https://utsouthwestern.pure.elsevier.com/en/publications/effect-of-dapagliflozin-on-urinary-albumin-excretion-in-patients-
https://www.thelancet.com/journals/landia/article/PIIS2213-8587(21)00243-6/fulltext
https://www.ncbi.nlm.nih.gov/pubmed/34619106 -
17
Autoren: et al.
Quelle: The Lancet Diabetes & Endocrinology. 9:743-754
Schlagwörter: Male, Kidney, Glomerular Filtration Rate/drug effects, Chronic/drug therapy, Placebos, Double-Blind Method, Glucosides, Benzhydryl Compounds/therapeutic use, Diabetes Mellitus, Humans, Diabetic Nephropathies, Renal Insufficiency/prevention & control, Renal Insufficiency, Benzhydryl Compounds, Renal Insufficiency, Chronic, Sodium-Glucose Transporter 2 Inhibitors, Aged, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Middle Aged, 16. Peace & justice, 3. Good health, Glucosides/therapeutic use, Type 2/drug therapy, Diabetes Mellitus, Type 2, Diabetic Nephropathies/drug therapy, Female, Kidney/physiopathology, Glomerular Filtration Rate
Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/34619108
https://hdl.handle.net/11370/605e73ec-9c12-42a7-a999-35d7cf1a8d4c
https://research.rug.nl/en/publications/605e73ec-9c12-42a7-a999-35d7cf1a8d4c
https://doi.org/10.1016/S2213-8587(21)00242-4
https://utsouthwestern.pure.elsevier.com/en/publications/effect-of-dapagliflozin-on-the-rate-of-decline-in-kidney-function
https://www.sciencedirect.com/science/article/pii/S2213858721002424
https://www.ncbi.nlm.nih.gov/pubmed/34619108
https://pubmed.ncbi.nlm.nih.gov/34619108/
https://www.thelancet.com/journals/landia/article/PIIS2213-8587(21)00242-4/fulltext -
18
Autoren: et al.
Quelle: Diabetologia
Schlagwörter: Adult, Blood Glucose, Blood Platelets, Male, 0301 basic medicine, Thrombin/metabolism [MeSH], Benzhydryl Compounds/therapeutic use [MeSH], Blood Platelets/metabolism [MeSH], HDL-cholesterol, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use [MeSH], Heart failure, Mice, Inbred C57BL [MeSH], P-Selectin/metabolism [MeSH], Flow Cytometry [MeSH], P-Selectin (CD62P), Atherosclerosis, Diabetes Mellitus, Type 2/drug therapy [MeSH], Platelet Activation/drug effects [MeSH], Sodium–glucose cotransporter 2 (SGLT2) inhibitors, Coronary Artery Disease/prevention, Male [MeSH], Risk Reduction Behavior [MeSH], Healthy Volunteers [MeSH], Platelets, Coronary Artery Disease/metabolism [MeSH], Cardiovascular Diseases/metabolism [MeSH], Female [MeSH], Adult [MeSH], Humans [MeSH], Dapagliflozin, Middle Aged [MeSH], Platelet Count [MeSH], Cardiovascular Diseases/prevention, Animals [MeSH], Cardiovascular, Immunohistochemistry [MeSH], Article, Glucosides/therapeutic use [MeSH], Cholesterol, HDL/blood [MeSH], Blood Glucose/metabolism [MeSH], Diabetes Mellitus, Type 2/metabolism [MeSH], Thrombin, Blood Platelets/drug effects [MeSH], Real-Time Polymerase Chain Reaction [MeSH], Coronary Artery Disease, 03 medical and health sciences, 0302 clinical medicine, Glucosides, Animals, Humans, Benzhydryl Compounds, Cholesterol, HDL, Middle Aged, Flow Cytometry, Platelet Activation, Immunohistochemistry, Healthy Volunteers, 3. Good health, Mice, Inbred C57BL, P-Selectin, Diabetes Mellitus, Type 2, Cardiovascular Diseases, Female
Zugangs-URL: https://link.springer.com/content/pdf/10.1007/s00125-021-05498-0.pdf
https://pubmed.ncbi.nlm.nih.gov/34131781
https://link.springer.com/article/10.1007/s00125-021-05498-0
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245397/
https://pubmed.ncbi.nlm.nih.gov/34131781/
https://europepmc.org/article/MED/34131781
https://link.springer.com/content/pdf/10.1007/s00125-021-05498-0.pdf
https://repository.publisso.de/resource/frl:6451904 -
19
Autoren: et al.
Quelle: JAMA cardiology. 6(6):678-689
Schlagwörter: Aged, Benzhydryl Compounds/*therapeutic use, Disease Progression, Female, Glucosides/*therapeutic use, Heart Failure/*drug therapy/mortality, Hospitalization/statistics & numerical data, Humans, Male, Quality of Life, Sodium-Glucose Transporter 2 Inhibitors/*therapeutic use, Stroke Volume
Dateibeschreibung: print
-
20
Autoren: et al.
Weitere Verfasser: et al.
Quelle: The Lancet Diabetes & Endocrinology. 8:845-854
Schlagwörter: Male, Adult, Blood Glucose, Adolescent, Albuminuria/prevention & control, Diabetes Mellitus, Type 1/drug therapy, Hypoglycemic Agents/therapeutic use, Biomarkers/analysis, Glycated Hemoglobin A/analysis, Diabetic Ketoacidosis, 03 medical and health sciences, 0302 clinical medicine, Double-Blind Method, Glucosides, Benzhydryl Compounds/therapeutic use, Albuminuria, Humans, Hypoglycemic Agents, Insulin, Benzhydryl Compounds, Aged, Glycated Hemoglobin, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Blood Glucose/analysis, Creatinine/blood, Middle Aged, Prognosis, 16. Peace & justice, 3. Good health, Diabetic Ketoacidosis/prevention & control, Glucosides/therapeutic use, Diabetes Mellitus, Type 1, Insulin/therapeutic use, Creatinine, young adult, Drug Therapy, Combination, Female, Glomerular filtration rate, Biomarkers, Follow-Up Studies, Glomerular Filtration Rate
Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/32946821
https://www.thelancet.com/journals/landia/article/PIIS2213-8587(20)30280-1/fulltext
https://pubmed.ncbi.nlm.nih.gov/32946821/
https://researchportal.helsinki.fi/en/publications/effect-of-dapagliflozin-as-an-adjunct-to-insulin-over-52-weeks-in
https://www.sciencedirect.com/science/article/abs/pii/S2213858720302801
https://www.ncbi.nlm.nih.gov/pubmed/32946821
https://biblio.vub.ac.be/vubir/(dd6fd859-f8d6-4143-8dc4-a72ad95f0e26).html
Full Text 
Full Text Finder 
Nájsť tento článok vo Web of Science